Impact of deceased donor multidrug-resistant bacterial organisms on organ utilization

Judith A Anesi1,2, Jennifer H Han3, Ebbing Lautenbach1,2,4

  • 1Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Insights

Donor multidrug-resistant organisms (MDROs) did not significantly impact organ utilization. However, multidrug-resistant Gram-negative organisms in deceased donors were linked to fewer organs transplanted and lower acceptance rates.

Area of Science:

  • Transplantation
  • Infectious Diseases
  • Organ Donation

Background:

  • The impact of multidrug-resistant organisms (MDROs) in deceased donors on organ utilization is not well understood.
  • Assessing this association is crucial for optimizing organ donor pool and transplant outcomes.

Purpose of the Study:

  • To evaluate the association between donor MDROs and organ utilization metrics.
  • To specifically investigate the effect of multidrug-resistant Gram-negative (MDR-GN) organisms on organ transplantation.

Main Methods:

  • Retrospective cohort study at 4 transplant centers (2015-2016).
  • Included deceased donors with at least one organ donation.
  • Analyzed donor cultures for MDROs and used multivariable regression to assess organ utilization (number of organs transplanted, match run acceptance).

Main Results:

  • No significant association between overall donor MDROs and organ utilization.
  • Donor MDR-GNs (2% of donors) were associated with a significant reduction in organs transplanted per donor (IRR 0.43).
  • Organs from MDR-GN positive donors were accepted significantly further down the match list (relative count 5.08).

Conclusions:

  • While infrequent, donor MDR-GNs significantly reduce organ utilization.
  • The increasing prevalence of MDR-GNs poses a potential threat to the donor pool.
  • Further research and strategies to mitigate the impact of MDR-GNs in organ donation are warranted.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
269
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
816
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
237
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
748